Diagnosis of HCM With AI-ECG

Last updated: March 4, 2024
Sponsor: Shanghai Zhongshan Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Circulation Disorders

Congestive Heart Failure

Cardiac Disease

Treatment

N/A

Clinical Study ID

NCT06287892
AI-ECG-HCM
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study aims to establish a diagnostic model of hypertrophic cardiomyopathy with artificial intelligence-enhanced electrocardiogram.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with HCM

Exclusion

Exclusion Criteria:

  • Patients with ventricular pacing

Study Design

Total Participants: 10000
Study Start date:
January 01, 2024
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • 180 Fenglin Road

    Shanghai, 200032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.